Barclays
SRGA

Barclays’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Barclays’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9
Closed – – 5752
2020
Q2 		$0 Sell
9
-618
-99% -$46K ﹤0.01% 6457
2020
Q1 		$32K Buy
+627
New +$65.5K ﹤0.01% 5464
2019
Q4 		– Hold
0
– – – 7026
2019
Q3 		– Sell
-1,278
Closed -$163K – 7317
2019
Q2 		$163K Buy
1,278
+1,270
+15,875% +$183K ﹤0.01% 5291
2019
Q1 		$1K Buy
+8
New +$1.16K ﹤0.01% 6953
2018
Q4 		– Sell
-775
Closed -$105K – 7528
2018
Q3 		$105K Buy
775
+635
+454% +$87.5K ﹤0.01% 5501
2018
Q2 		$20K Buy
140
+139
+13,900% +$19.1K ﹤0.01% 6203
2018
Q1 		$0 Sell
1
-291
-100% -$39.6K ﹤0.01% 7460
2017
Q4 		$36K Buy
292
+249
+579% +$34.2K ﹤0.01% 5954
2017
Q3 		$6K Sell
43
-295
-87% -$44.5K ﹤0.01% 6376
2017
Q2 		$60K Buy
338
+329
+3,656% +$46.8K ﹤0.01% 5245
2017
Q1 		$1K Sell
9
-25
-74% -$2.6K ﹤0.01% 6668
2016
Q4 		$3K Buy
34
+22
+183% +$2.02K ﹤0.01% 6291
2016
Q3 		$1K Buy
+12
New +$1.2K ﹤0.01% 6492
2015
Q4 		– Sell
-10
Closed -$2K – 6779
2015
Q3 		$2K Sell
10
-27
-73% -$5.17K ﹤0.01% 6410
2015
Q2 		$7K Sell
37
-19
-34% -$3.53K ﹤0.01% 6297
2015
Q1 		$7K Sell
56
-52
-48% -$7.92K ﹤0.01% 6463
2014
Q4 		$16K Sell
108
-266
-71% -$38.3K ﹤0.01% 6454
2014
Q3 		$44K Sell
374
-314
-46% -$45.5K ﹤0.01% 5988
2014
Q2 		$83K Buy
688
+611
+794% +$77.6K ﹤0.01% 5568
2014
Q1 		$9K Buy
77
+32
+71% +$3.47K ﹤0.01% 6986
2013
Q4 		$3K Sell
45
-413
-90% -$40.1K ﹤0.01% 7296
2013
Q3 		$42K Sell
458
-663
-59% -$75.2K ﹤0.01% 6157
2013
Q2 		$127K Buy
+1,121
New +$137K ﹤0.01% 5591

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays's SRGA Position: Q3 2020 in Review

Barclays sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2020, closing a stake of 9 shares.

Barclays first reported a position in SRGA in Q2 2013 and held it in 23 quarters. The position peaked at $163K in Q2 2019. 89 funds tracked by Wall St. Rank hold SRGA as of Q3 2020.

  • Barclays reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Barclays sold 9 Surgalign Holdings, Inc. Common Stock shares in Q3 2020.
  • Barclays first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
  • Barclays's Surgalign Holdings, Inc. Common Stock position peaked at $163K in Q2 2019.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2020.

Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.